EUVIMEDEUVIMED entdecken
Crossref

Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis

Yongxian Hu, Mingming Zhang, Tingting Yang, Zhuomao Mo, Guoqing Wei, Ruirui Jing, Houli Zhao, Rongrong Chen, Cheng Zu iD, Tianning Gu, Pingnan Xiao, Ruimin Hong und 17 weitere

New England Journal of Medicine · 25.04.2024 · 390 (16) · 1467-1480

DOI: 10.1056/nejmoa2313812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 25.04.2024. Verfasst von Yongxian Hu und 28 weiteren Autor:innen. Beteiligte Einrichtung: From the Bone Marrow Transplantation Center, First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine (Y.H., M.Z., …. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Immunotherapy, Adoptive, Leukemia. Die Arbeit wurde bisher 135-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Science and Technology Department of Zhejiang Province, National Natural Science Foundation of China, Key Project of Science and Technology Department of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationImmunotherapy, AdoptiveLeukemiaLymphomaReceptors, Chimeric AntigenAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultAntigens, CD7Combined Modality TherapyRemission InductionTransplantation, HomologousRecurrenceAged

Substanzen

Antigens, CD7Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • From the Bone Marrow Transplantation Center, First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine (Y.H., M.Z., T.Y., Z.M., G.W., R.J., H.Z., R.C., C.Z., T.G., P.X., R.H., J.F., S.F.…

ORCID-Profile: Cheng Zu

Förderung

  • Science and Technology Department of Zhejiang Province
  • National Natural Science Foundation of China
  • Key Project of Science and Technology Department of Zhejiang Province

Zitieren

APA

Hu, Y., Zhang, M., Yang, T., Mo, Z., Wei, G., Jing, R., Zhao, H., Chen, R., Zu, C., Gu, T., Xiao, P., Hong, R., Feng, J., Fu, S., Kong, D., Xu, H., Cui, J., Huang, S., Liang, B., …, & Huang, H. (2024). Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis. New England Journal of Medicine, 390(16), 1467-1480. https://doi.org/10.1056/nejmoa2313812

Vancouver

Hu Y, Zhang M, Yang T, Mo Z, Wei G, Jing R, et al. Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis. New England Journal of Medicine. 2024;390(16):1467-1480. doi:10.1056/nejmoa2313812

BibTeX
@article{Hu2024,
  author = {Hu, Yongxian and Zhang, Mingming and Yang, Tingting and Mo, Zhuomao and Wei, Guoqing and Jing, Ruirui and Zhao, Houli and Chen, Rongrong and Zu, Cheng and Gu, Tianning and Xiao, Pingnan and Hong, Ruimin and Feng, Jingjing and Fu, Shan and Kong, Delin and Xu, Huijun and Cui, Jiazhen and Huang, Simao and Liang, Bin and Yuan, Xiaolin and Cui, Qu and Guo, Hongshan and Yu, Yunxian and Feng, Youqin and Jin, Chunxiang and Ren, Jiangtao and Chang, Alex H and Wang, Dongrui and Huang, He},
  title = {Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {16},
  pages = {1467--1480},
  doi = {10.1056/nejmoa2313812}
}
Kostenlos starten →